Lawyer profile
Josh Holian
Latham & Watkins LLP
- Firm
- Latham & Watkins LLP
- Practice
- antitrust, antitrust/regulatory, regulatory
- Office
- Bay Area
- Active in the record
- 2021 to 2026
Deal experience
Recent deals
13 announced deals in the record Latham & Watkins Advises BridgeBio on Up to US$1 Billion Preferred Equity Investment, One of the Largest Preferred Investments for Public Biotechs Ever and the Largest in 2026 2 Jul 2026
Latham & Watkins Advises EFC Gases & Advanced Materials in Acquisition by Element Solutions Inc 11 Nov 2025
Latham & Watkins Advises Invetx in Acquisition by Dechra Pharmaceuticals 19 Jul 2024
Latham & Watkins Advises Teachers’ Curriculum Institute in Equity Investment by Francisco Partners 6 Jun 2024
Latham & Watkins Advises WalkMe in US$1.5 Billion Acquisition by SAP SE 6 Jun 2024
Latham & Watkins Advises Coherus BioSciences in Divestment of Ophthalmology Franchise to Sandoz 22 Jan 2024
Latham & Watkins Advises Laminar, Inc. in US$400 Million Acquisition by Johnson & Johnson Medtech 6 Dec 2023
Latham & Watkins Advises SK Capital in Acquisition of Milestone Environmental Services 13 Oct 2023
Latham & Watkins Advises NextGen Healthcare in Acquisition by Thoma Bravo 7 Sept 2023
Latham & Watkins Advises Prometheus Biosciences in US$10.8 Billion Acquisition by Merck 18 Apr 2023
Deal alerts PRO
Get an email when Josh Holian is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile